✦ LIBER ✦

Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma

✍ Scribed by Thieblemont, C; Dumontet, C; Saad, H; Roch, N; Bouafia, F; Arnaud, P; Hequet, O; Espinouse, D; Salles, G; Roy, P

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose idarubicine, busulphan and mel

✍ Meloni, G; Capria, S; Trasarti, S; Ferrazza, G; Micozzi, A; Petrucci, M T; Simon 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 57 KB

High-dose chemotherapy and autologous pe

✍ Ballester, O F; Tummala, R; Janssen, W E; Fields, K K; Hiemenz, J W; Goldstein, 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

Hemophagocytic syndrome after autologous

✍ Ostronoff, M; Ostronoff, F; Coutinho, M; Calixto, R; Souto Maior, A P; Sucupira, 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 75 KB

Myeloma cell contamination of peripheral

✍ Wichard Vogel; Hans-Georg Kopp; Lothar Kanz; Hermann Einsele 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 245 KB

High-dose melphalan versus busulfan, cyc

✍ Don M. Benson Jr.; Patrick J. Elder; Thomas S. Lin; William Blum; Sam Penza; Bel 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Molecular monitoring of the tumor load p

✍ Lipinski, E; Cremer, F W; Ho, A D; Goldschmidt, H; Moos, M 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 172 KB